top of page
News
We're thrilled to share the latest developments from our company.
Suche
Publication of half-year report 2024/2025
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July 2024 – December 2024. The report is...
ODI Pharma
27. Feb.3 Min. Lesezeit
0 Kommentare
ODI Pharma terminates the agreement with liquidity provider
ODI Pharma AB ("ODI Pharma") hereby informs the termination of the agreement regarding the liquidity provider with Pareto Securities AB....
ODI Pharma
16. Jan.1 Min. Lesezeit
0 Kommentare
Announcement from the Annual General Meeting in ODI Pharma AB (publ)
Today, the 30th of December 2024, ODI Pharma AB (publ) held its Annual General Meeting (“AGM”). A summary of the resolutions follows...
ODI Pharma
30. Dez. 20243 Min. Lesezeit
0 Kommentare
Kommuniké från årsstämma i ODI Pharma AB (publ)
Idag den 30 december 2024 hölls årsstämma i ODI Pharma AB (publ). Nedan följer en sammanfattning av de beslut som fattades. Samtliga...
ODI Pharma
30. Dez. 20242 Min. Lesezeit
0 Kommentare
ODI Pharma AB announces last day of trading in BTA
ODI Pharma AB’s ("ODI" or the "Company") preferential issue of shares, with a subscription period ending on December 10, 2024, has now...
ODI Pharma
19. Dez. 20244 Min. Lesezeit
0 Kommentare
Flagging notification
ODI Pharma AB ("ODI Pharma") hereby informs that the current CEO, Derek Simmross, did not subscribe to his pro-rata in the completed...
ODI Pharma
13. Dez. 20241 Min. Lesezeit
0 Kommentare
ODI Pharma AB publishes outcome of rights issue
The subscription period in ODI Pharma AB’s ("ODI" or the "Company") issue of shares with preferential right (the “Rights Issue”) ended on...
ODI Pharma
11. Dez. 20244 Min. Lesezeit
0 Kommentare
ODI Pharma achieved market share targets in 2024 and increases its targets for 2025. Positioned for growth as Poland's medical cannabis market expands
O DI Pharma AB ("ODI" or the "Company") provides an update on Poland’s expanding medical cannabis market, which remains an important...
ODI Pharma
4. Dez. 20242 Min. Lesezeit
0 Kommentare
ODI Pharma AB publishes the annual report for the fiscal year 2023/2024
The Board of Directors and the Chief Executive Officer of ODI Pharma AB (“ODI Pharma”) hereby publishes the annual report for the fiscal...
ODI Pharma
2. Dez. 20242 Min. Lesezeit
0 Kommentare
ODI Pharma AB publicerar årsredovisning för räkenskapsåret 2023/2024
Styrelsen och verkställande direktören för ODI Pharma AB ("ODI Pharma") publicerar härmed årsredovisningen för räkenskapsåret 2023/2024....
ODI Pharma
2. Dez. 20241 Min. Lesezeit
0 Kommentare
Notice to Annual General Meeting in ODI Pharma AB (publ)
The shareholders of ODI Pharma AB (publ), 559223–1392, are hereby invited to attend the Annual General Meeting on Monday, 30th of...
ODI Pharma
27. Nov. 20245 Min. Lesezeit
0 Kommentare
Kallelse till årsstämma i ODI Pharma AB (publ)
Aktieägarna i ODI Pharma AB (publ), 559223–1392, kallas härmed till årsstämma måndagen den 30 december 2024 kl. 10:00 i bolagets lokaler...
ODI Pharma
27. Nov. 20244 Min. Lesezeit
0 Kommentare
The subscription period in ODI Pharma AB’s preferential rights issue commences today
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA,...
ODI Pharma
26. Nov. 20247 Min. Lesezeit
0 Kommentare
ODI Pharma AB publishes memorandum prior to preferential rights issue
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA,...
ODI Pharma
25. Nov. 20244 Min. Lesezeit
0 Kommentare
Publication of interim report Q1 2024/2025
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report for the period July 2024 – September 2024. The report is...
ODI Pharma
22. Nov. 20243 Min. Lesezeit
0 Kommentare
ODI Pharma moves the AGM and postpones the publication of Annual Report 2023/2024
ODI Pharma AB (“ODI” or the “Company”) hereby hereby announces that the Company, due to administrative reasons, chooses to move the...
ODI Pharma
22. Nov. 20242 Min. Lesezeit
0 Kommentare
Report from the Extraordinary General Meeting on 19 November in ODI Pharma AB (publ)
Today, 19 November 2024, an Extraordinary General Meeting was held in ODI Pharma AB (publ), reg. no. 559223-1392. Below is a summary of...
ODI Pharma
19. Nov. 20243 Min. Lesezeit
0 Kommentare
Kommuniké från extra bolagsstämma den 19 november i ODI Pharma AB (publ)
Idag, den 19 november 2024, hölls extra bolagsstämma i ODI Pharma AB (publ), org. nr. 559223-1392. Nedan följer en sammanfattning av de...
ODI Pharma
19. Nov. 20242 Min. Lesezeit
0 Kommentare
Updated Notice of Annual General Meeting in ODI Pharma AB (publ)
The shareholders of ODI Pharma AB (publ), 559223-1392, are hereby summoned to the Annual General Meeting on Friday, December 13, 2024, at...
ODI Pharma
13. Nov. 20246 Min. Lesezeit
0 Kommentare
Uppdaterad kallelse till årsstämma i ODI Pharma AB (publ)
Aktieägarna i ODI Pharma AB (publ), 559223-1392, kallas härmed till årsstämma fredagen den 13 december 2024 kl. 10:00 i bolagets lokaler...
ODI Pharma
13. Nov. 20245 Min. Lesezeit
0 Kommentare
bottom of page